Intas Pharmaceuticals

Intas Pharma signs licensing pact with mAbxience for etanercept biosimilar

Read more

Intas Pharma and Comera Life Sciences enter into a research partnership

Read more

Intas launches Oral Azacitidine for adult patients with Acute Myeloid Leukaemia

Read more

UK fines pharma companies $360 million for overcharging NHS

Read more

NPPA fixes retail prices of 30 formulations, rejects four applications

Read more

NPPA fixes retail prices for 14 formulations

Read more

RPG Life Sciences to sell off its biotech unit

Read more

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Read more

Intas Pharmaceuticals launches INTACEPT, the first etanercept biosimilar

Read more

Intas Pharmaceuticals launches biosimilar in Europe

Read more